CYSTARAN
NDC 54482-035, cysteamine hydrochloride, solution, from Leadiant Biosciences, Inc..
- Product NDC
- 54482-035
- Status
- Listed
- Labeler
- Leadiant Biosciences, Inc.
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA200740
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54482-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYSTEAMINE HYDROCHLORIDE6.5 mg/mL
Pharmacologic classes
Cystine Depleting Agent [EPC]; Cystine Disulfide Reduction [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54482-035-02 | 54482003502 | 15 mL in 1 BOTTLE (54482-035-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b98ee838-ed23-42a9-93b5-72579e490fba
Use it
Look up 54482-035 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54482-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54482-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.